Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.80 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LCK | P06239 | 1/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.59 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6657056 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL545070 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| Dodecane SCHEMBL14691319 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL194398 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL247871 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL22023412 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL7080552 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL7146627 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL2054033 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL277986 | 1.00 | ACE2 (0.80) | ACE2GPR84CA1FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4262368-B1 | WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS | VIRBAC (FR) | 2026-01-28 | — | — | EP | claimed |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2020-10-06 | — | — | US | claimed |
| EP-3661600-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME | Epitracker, Inc. (US) | 2020-06-10 | — | — | EP | claimed |
| US-20180148744-A1 | BIOLOGICAL METHODS FOR PREPARING 3-HYDROXYPROPIONIC ACID | VERDEZYNE INC (US) | 2018-05-31 | — | — | US | claimed |
| EP-2644185-B1 | THICK CLEANING COMPOSITION | SUZHOU ELECO CHEMICAL IND CO LTD (CN) | 2018-04-25 | — | — | EP | claimed |
| CN-103338743-B | A kind of Cleasing compositions of stiff | SUZHOU YUANSUJI CHEMICAL INDUSTRY Co.,Ltd. (CN) | 2016-06-01 | — | — | CN | claimed |
| US-9283442-B2 | Golf ball | DUNLOP SPORTS CO. LTD. (JP) | 2016-03-15 | — | — | US | claimed |
| EP-2644185-A1 | THICK CLEANING COMPOSITION | Suzhou Yuansuji Chemical Industry Co., Ltd. (CN) | 2013-10-02 | — | — | EP | claimed |
| US-20130251648-A1 | THICK CLEANING COMPOSITION | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO., LTD. (CN) | 2013-09-26 | — | — | US | claimed |
| WO-2013134656-A1 | INDUCTION OF TH17 IMMUNE RESPONSE | GENOCEA BIOSCIENCES, INC. (US) | 2013-09-12 | — | — | WO | claimed |
| US-20050153869-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2005-07-14 | — | — | US | claimed |
| US-5536436-A | DETERGENT, LIPOLYTIC ENZYME, BUILDERS AND SOAPS | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-16 | — | — | US | claimed |
| WO-1995033041-A1 | LIQUID LAUNDRY DETERGENT COMPOSITIONS CONTAINING LIPOLYTIC ENZYME AND SPECIALLY SELECTED SOAPS | THE PROCTER & GAMBLE COMPANY (US) | 1995-12-07 | — | — | WO | claimed |
| WO-1995033044-A1 | LIQUID LAUNDRY DETERGENT COMPOSITIONS COMPRISING SPECIALLY SELECTED SOAPS | THE PROCTER & GAMBLE COMPANY (US) | 1995-12-07 | — | — | WO | claimed |
| US-5380892-A | Clathrates | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-01-10 | — | — | US | claimed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | RESONAC CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| US-4544794-A | NEO ACID AND FATTY ACID | ATLANTIC RICHFIELD COMPANY (US) | 1985-10-01 | — | — | US | disclosed |
| EP-0108645-A2 | Novel ailanthone derivative | SUNTORY LIMITED (JP) | 1984-05-16 | — | — | EP | disclosed |
| US-4440666-A | Method of making corrosion inhibiting polyamine amides, the amides, and use therefor | ATLANTIC RICHFIELD CO. (US) | 1984-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | FABP1, FASN, GPR119 | ACE2 1787/4885GPR84 598/4885CA1 3525/4885 |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | DCX, DNAJA2, DNAJA1 | ACE2 2558/4885GPR84 4417/4885CA1 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.